National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 7/26/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Wallace Akerley, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
BioMarin;
Biotheranostics;
Clarient Consulting

None

None

None

Lyudmila Bazhenova, MD

None

None

None

None

None

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Genentech, Inc.

None

None

None

David Ross Camidge, MD, PhD

None

None

None

None

None

Andrew C. Chang, MD

None

None

None

None

None

Richard T. Cheney, MD

None

OptumHealth

None

None

None

Lucian R. Chirieac, MD

None

Boehringer Ingelheim GmbH;
Aposense;
Infinity;
Shook,Hardy&Bacon

None

None

None

Thomas A. D'Amico, MD

None

Scanlan

None

None

None

Todd L. Demmy, MD

None

None

None

None

None

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix;
Gilead;
Roche Laboratories, Inc.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Covidien AG;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.

None

None

None

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

City of Hope National Medical Center Board of Directors

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Leora Horn, MD, MSc, FRCPC

None

Bristol-Myers Squibb Company

None

None

None

Miranda Hughes, PhD

None

None

None

None

None

Thierry M. Jahan, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Ritsuko Komaki, MD

ACRIN

None

None

None

None

Mark G. Kris, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Bind Biosciences;
Clovis Oncology, Inc;
Esanex, Inc;
Roche Laboratories, Inc.

None

None

None

Lee M. Krug, MD

None

Genentech, Inc.;
MedImmune Inc.;
Morphotek Inc.

None

None

None

Rudy P. Lackner, MD

None

None

None

None

None

Inga T. Lennes, MD, MPH, MBA

None

None

None

None

None

Billy W. Loo, MD, PhD

None

Siemens Medical Solutions Diagnostics;
Varian Medical Systems, Inc.

None

None

None

Christine M. Lovly, MD, PhD

None

Clinvaluate

None

None

None

Renato Martins, MD, MPH

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Gregory A. Otterson, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.

None

None

None

Jyoti D. Patel, MD

None

Genentech, Inc.

None

None

None

Mary C. Pinder-Schenck, MD

Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Pfizer Inc.

None

None

None

None

Katherine M. Pisters, MD

None

None

None

None

None

Karen Reckamp, MD, MS

None

Amgen Inc.;
Boehringer Ingelheim GmbH

None

None

None

Gregory J. Riely, MD, PhD

None

Celgene Corporation;
Daiichi- Sankyo Co.;
Chugai

None

None

None

Eric Rohren, MD, PhD

None

None

None

None

None

Theresa A. Shapiro, MD, PhD

None

None

None

None

None

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

None

Kurt Tauer, MD, FACP

None

Eli Lilly and Company

None

None

None

Douglas E. Wood, MD

None

Lung Cancer Alliance

None

None

None

Stephen C. Yang, MD

None

None

None

None

None